{"name": "Precision Biologics",
 "permalink": "precision-biologics",
 "crunchbase_url": "http://www.crunchbase.com/company/precision-biologics",
 "homepage_url": "http://precision-biologics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": 2,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@precision-biologics.com",
 "phone_number": "214-696-4999",
 "description": "",
 "created_at": "Sat May 25 03:15:33 UTC 2013",
 "updated_at": "Sat May 25 04:27:31 UTC 2013",
 "overview": "\u003Cp\u003EFounded in February 2012 and commencing business in late September 2012, Precision Biologics, Inc. is a clinical stage biotechnology corporation focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer.\u003C/p\u003E\n\n\u003Cp\u003EThe company\u2019s antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Precision Biologics is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials.\u003C/p\u003E\n\n\u003Cp\u003EBy marrying this platform with today\u2019s breakthrough technologies, the company is developing antibody therapeutics that could change the way we detect and treat cancer.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0026/6759/266759v1-max-150x150.png"],
     [[250,
       66],
      "assets/images/resized/0026/6759/266759v1-max-250x250.png"],
     [[376,
       100],
      "assets/images/resized/0026/6759/266759v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$5.48M",
 "funding_rounds":
  [{"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1560075/000156007513000002/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 3289327.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 21,
    "investments":
     []},
   {"round_code": "partial",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1560075/000156007513000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 2192885.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 3,
    "funded_day": 31,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "5910 North Central Expressway",
    "address2": "Suite 1300",
    "zip_code": "75206",
    "city": "Dallas",
    "state_code": "TX",
    "country_code": "USA",
    "latitude": 32.8385705,
    "longitude": -96.7753852}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        80],
       "assets/images/resized/0026/6758/266758v1-max-150x150.png"],
      [[250,
        134],
       "assets/images/resized/0026/6758/266758v1-max-250x250.png"],
      [[450,
        241],
       "assets/images/resized/0026/6758/266758v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}